Pure Global

Evaluation of the Impact of Therapeutic Education Workshops for COPD Patients in the North-West Val d'Oise Area - Trial NCT06298487

Access comprehensive clinical trial information for NCT06298487 through Pure Global AI's free database. This phase not specified trial is sponsored by Hôpital NOVO and is currently Recruiting. The study focuses on COPD. Target enrollment is 100 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT06298487
Recruiting
other
Trial Details
ClinicalTrials.govNCT06298487
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Evaluation of the Impact of Therapeutic Education Workshops for COPD Patients in the North-West Val d'Oise Area
Evaluation of the Multidimensional Impact of Therapeutic Education Workshops for COPD Patients, Cared for by the Maison de Prévention de la Santé et d'Accompagnement Thérapeutique, in the North-West Val d'Oise Area

Study Focus

COPD

Patient questionnaires

Interventional

other

Sponsor & Location

Hôpital NOVO

Pontoise, France

Timeline & Enrollment

N/A

Mar 11, 2024

Sep 01, 2024

100 participants

Primary Outcome

Evaluation of the overall impact of the PTE workshops offered by the MPSAT on patients' knowledge, skills, attitudes and behaviours with regard to COPD management and care

Summary

The aim of this study is to assess the impact of the Patient Therapeutic Education (PTE)
 workshops offered by the Maison de Prévention de la Santé et d'Accompagnement Thérapeutique
 (MPSAT) on the follow-up and feelings of the COPD patients who take part. These workshops are
 organised outside the hospital environment and supervised by hospital and town professionals
 in the NOVO zone.

ICD-10 Classifications

Chronic obstructive pulmonary disease, unspecified
Other chronic obstructive pulmonary disease
Other specified chronic obstructive pulmonary disease
Chronic obstructive pulmonary disease with acute exacerbation, unspecified
Pulmonary heart disease, unspecified

Data Source

ClinicalTrials.gov

NCT06298487

Non-Device Trial